CD28 and neoplasm: Among all patients and the subgroup of patients treated with PD-1 inhibitors, CD8+CD28+ T cells and NK cells were identified as the common independent prognostic factors for PFS and OS (Figure 5), whereas CD8+CD38+ T cells were common independent prognostic factors for tumor response.